“High Risk” LGG according to European criteria
477 patients were randomly assigned to receive either 50.4 Gy RT (240) or TMZ (237)
RT vs TMZ in HR LGG: EORTC 22033
Baumert BG et al. Lancet Oncol 2016;17
Median PFS: 46 (RT) vs 39 (TMZ) months
p = 0.22




